0001214659-24-011873.txt : 20240702
0001214659-24-011873.hdr.sgml : 20240702
20240702173345
ACCESSION NUMBER: 0001214659-24-011873
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240613
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Caroline
CENTRAL INDEX KEY: 0001684087
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 241097266
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE, SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
marketforms-66487.xml
PRIMARY DOCUMENT
X0508
4
2024-06-13
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001684087
Young Caroline
1600 WEST END AVENUE
SUITE 1300
NASHVILLE
TN
37203
true
false
false
false
1
Common Stock
2024-06-13
5
L
false
E
25
1.52
A
26726
D
Common Stock
2024-06-14
5
L
false
E
48
1.50
A
26774
D
Common Stock
2024-06-17
5
L
false
E
41
1.49
A
26815
D
Common Stock
2024-06-18
5
L
false
E
41
1.57
A
26856
D
Common Stock
2024-06-20
5
L
false
E
41
1.53
A
26897
D
Common Stock
2024-06-21
5
L
false
E
41
1.49
A
26938
D
Common Stock
2024-06-24
5
L
false
E
21
1.59
A
26959
D
Common Stock
2024-06-25
5
L
false
E
21
1.54
A
26980
D
Common Stock
2024-06-26
5
L
false
E
21
1.50
A
27001
D
Common Stock
2024-06-27
5
L
false
E
21
1.52
A
27022
D
Common Stock
2024-06-28
5
L
false
E
20
1.50
A
27042
D
The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
Caroline Young by /s/ John Hamm as attorney-in-fact
2024-07-02